UK & European Research At A Glance

This report provides a summary of RBC Capital Markets' research across UK and European equities, covering rating changes, valuation overviews, and sector outlooks as of July 3, 2026.

Key Takeaways

• 1.Pan-European Capital Goods profits are projected to grow 14% in H2 2026.
• 2.Biopharma funding shows strong momentum with June up 123% and 2026 YTD up 136%.
• 3.European Majors in the energy sector continue to trade at a discount to North American Majors.

Table of Contents

• Premium Research
• Rating Revisions
• Company Comments
• Industry Comments
• Quick Takes
• Disclaimer

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial